Literature DB >> 18608088

Heterozygous S44L missense change of the spastin gene in amyotrophic lateral sclerosis.

Christoph Münch1, Arndt Rolfs, Thomas Meyer.   

Abstract

The authors present a 50-year-old patient with adult-onset amyotrophic lateral sclerosis (ALS) that was rapidly progressing. Screening of the spastin gene revealed a heterozygous missense change S44L. We excluded the involvement of the ALS-linked gene for copper/zinc superoxide dismutase (SOD1). This unusual phenotype shows that allelic variants of spastin may predispose bearers to a greater spectrum of motor neuron disorders including ALS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18608088     DOI: 10.1080/17482960801900172

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler        ISSN: 1471-180X


  6 in total

Review 1.  Familial Amyotrophic Lateral Sclerosis.

Authors:  Kevin Boylan
Journal:  Neurol Clin       Date:  2015-09-08       Impact factor: 3.806

2.  Mutation screening of spastin, atlastin, and REEP1 in hereditary spastic paraplegia.

Authors:  D S McCorquodale; U Ozomaro; J Huang; G Montenegro; A Kushman; L Citrigno; J Price; F Speziani; M A Pericak-Vance; S Züchner
Journal:  Clin Genet       Date:  2011-06       Impact factor: 4.438

3.  Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways.

Authors:  Elizabeth T Cirulli; Brittany N Lasseigne; Slavé Petrovski; Peter C Sapp; Patrick A Dion; Claire S Leblond; Julien Couthouis; Yi-Fan Lu; Quanli Wang; Brian J Krueger; Zhong Ren; Jonathan Keebler; Yujun Han; Shawn E Levy; Braden E Boone; Jack R Wimbish; Lindsay L Waite; Angela L Jones; John P Carulli; Aaron G Day-Williams; John F Staropoli; Winnie W Xin; Alessandra Chesi; Alya R Raphael; Diane McKenna-Yasek; Janet Cady; J M B Vianney de Jong; Kevin P Kenna; Bradley N Smith; Simon Topp; Jack Miller; Athina Gkazi; Ammar Al-Chalabi; Leonard H van den Berg; Jan Veldink; Vincenzo Silani; Nicola Ticozzi; Christopher E Shaw; Robert H Baloh; Stanley Appel; Ericka Simpson; Clotilde Lagier-Tourenne; Stefan M Pulst; Summer Gibson; John Q Trojanowski; Lauren Elman; Leo McCluskey; Murray Grossman; Neil A Shneider; Wendy K Chung; John M Ravits; Jonathan D Glass; Katherine B Sims; Vivianna M Van Deerlin; Tom Maniatis; Sebastian D Hayes; Alban Ordureau; Sharan Swarup; John Landers; Frank Baas; Andrew S Allen; Richard S Bedlack; J Wade Harper; Aaron D Gitler; Guy A Rouleau; Robert Brown; Matthew B Harms; Gregory M Cooper; Tim Harris; Richard M Myers; David B Goldstein
Journal:  Science       Date:  2015-02-19       Impact factor: 47.728

4.  Valproate Treatment in an ALS Patient Carrying a c.194G>A Spastin Mutation and SMN2 Homozygous Deletion.

Authors:  Lucio Tremolizzo; Gessica Sala; Elisa Conti; Virginia Rodriguez-Menendez; Antonella Fogli; Angela Michelucci; Paolo Simi; Silvana Penco; Christian Lunetta; Massimo Corbo; Carlo Ferrarese
Journal:  Case Rep Neurol Med       Date:  2014-07-17

Review 5.  The Neglected Genes of ALS: Cytoskeletal Dynamics Impact Synaptic Degeneration in ALS.

Authors:  María José Castellanos-Montiel; Mathilde Chaineau; Thomas M Durcan
Journal:  Front Cell Neurosci       Date:  2020-11-13       Impact factor: 5.505

6.  Targeted sequencing panels in Italian ALS patients support different etiologies in the ALS/FTD continuum.

Authors:  Anna Bartoletti-Stella; Veria Vacchiano; Rocco Liguori; Sabina Capellari; Silvia De Pasqua; Giacomo Mengozzi; Dario De Biase; Ilaria Bartolomei; Patrizia Avoni; Giovanni Rizzo; Piero Parchi; Vincenzo Donadio; Adriano Chiò; Annalisa Pession; Federico Oppi; Fabrizio Salvi
Journal:  J Neurol       Date:  2021-03-26       Impact factor: 4.849

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.